Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 11/03/15

Kim Witherspoon

Kim Witherspoon


Ms. Kim Witherspoon became part CTEP’s Clinical Grants and Contracts Branch (CGCB) in September 2000. She is responsible for the administrative management and oversight of the CGCB grant portfolio. Kim ensures grantee policy and regulatory compliance, particularly in the areas of human subjects research protections and inclusion of women and minorities in clinical research. She is Senior Program Specialist for the Experimental Therapeutics Clinical Trials Network (ETCTN). She performs duties as a Program Director, a Level II FAC-Contract Officer's Representative (COR), and Program Analyst. Her portfolio includes clinical research projects focused on human subject research protections, minority and health disparities, clinical trial design, data and safety monitoring, bioethics, statistics, and software design.

Kim graduated from the University of Kansas in 1981 with a Bachelor of Science degree in Microbiology. After graduation, she worked as a Production Technician for Meloy Laboratories, a subsidiary of Revlon. In September 1982, Kim began her career as a federal government employee working for the Department of Defense. As a Biological Laboratory Technician in a Department of Medicine research laboratory at the Uniformed Services University of the Health Sciences (USUHS), she rapidly advanced to become the laboratory manager and co-author on a number of scientific publications. After 18 years of service at USUHS, she accepted a position as a Biologist in CTEP. Between 2009 and 2010 Kim received her dual Master degrees from the University of Maryland University College in Business Administration and Biotechnology specializing in Biodefense and Biosecurity.

About the Branch Chief

Vikram Devgan, Ph.D., MBA Vikram Devgan, Ph.D., MBA. joined the National Cancer Institute in 2016 as a Chief of Clinical Grants and Contracts Branch of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis. From 2006 to 2016, Dr. Devgan held positions of increasing responsibilities with QIAGEN Inc., rising to Head of the Center of Excellence for Biological Research Content. More…